Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Sage Therapeutics, Inc. (SAGE) had Receiveable Turnover of 1.04 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$86.45M |
|
$-541.49M |
|
$2.16M |
|
$84.30M |
|
$666.30M |
|
$-579.85M |
|
$38.36M |
|
$-541.49M |
|
$-541.49M |
|
$-541.49M |
|
$-541.49M |
|
$-541.49M |
|
$-541.49M |
|
$-579.85M |
|
$-584.80M |
|
59.84M |
|
59.84M |
|
$-9.05 |
|
$-9.05 |
|
| Balance Sheet Financials | |
$869.35M |
|
$1.92M |
|
$12.93M |
|
$882.28M |
|
$82.75M |
|
-- |
|
-- |
|
$82.75M |
|
$799.53M |
|
$799.53M |
|
$799.53M |
|
60.04M |
|
| Cash Flow Statement Financials | |
$-540.59M |
|
$442.91M |
|
$6.03M |
|
$163.97M |
|
$72.32M |
|
$-91.64M |
|
$73.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
97.50% |
|
-670.69% |
|
-670.69% |
|
-676.42% |
|
-626.32% |
|
-626.32% |
|
$-541.14M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
|
Receiveable Turnover |
1.04 |
350.45 |
|
-67.73% |
|
-67.73% |
|
-61.37% |
|
-67.73% |
|
$13.32 |
|
$-9.04 |
|
$-9.03 |
|